REQUEST A DEMO
Total
USD $0.00
Search more companies

Agave Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Agave Pharma Kft. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Agave Pharma Kft. is based in Hungary, with the head office in Szazhalombatta. The enterprise currently operates in the Pharmacies and Drug Stores sector. Agave Pharma Kft. was incorporated on August 31, 2020. It currently has a total number of 6 (2023) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 4.56% in 2022. There was a total growth of 19.21% in Agave Pharma Kft.’s total assets over the same period. The net profit margin of Agave Pharma Kft. decreased by 0.87% in 2022.

Headquarters
Kodaly Zoltan setany 22.
Szazhalombatta; Pest; Postal Code: 2440

Contact Details: Purchase the Agave Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Agave Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Agave Pharma Kft. report to view the information.
Registered Capital:
Purchase the Agave Pharma Kft. report to view the information.
Incorporation Date:
August 31, 2020
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Agave Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
4.56%
Total operating revenue
4.69%
Operating profit (EBIT)
-27.89%
EBITDA
-22.38%
Net Profit (Loss) for the Period
-45.83%
Total assets
19.21%
Total equity
41.62%
Operating Profit Margin (ROS)
-0.72%
Net Profit Margin
-0.87%
Return on Equity (ROE)
-47.47%
Quick Ratio
-0.01%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?